CohBar, Inc. Profile Avatar - Palmy Investing

CohBar, Inc.

CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatiti…

Biotechnology
US, Menlo Park [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

CohBar, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

CohBar, Inc. can't present revenue by segment

End of CWBR's Analysis
CIK: 1522602 CUSIP: 19249J109 ISIN: US19249J3077 LEI: - UEI: -
Secondary Listings
CWBR has no secondary listings inside our databases.